Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Consolidated Net Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
Consolidated Net Profit ₹25 Cr₹20 Cr₹20 Cr₹11 Cr₹10 Cr

What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Consolidated Net Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹25 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹25 Cr
Mar2023₹20 Cr
Mar2022₹20 Cr
Mar2017₹11 Cr
Mar2016₹10 Cr

How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹25 Cr
26.12
Mar2023 ₹20 Cr
1.42
Mar2022 ₹20 Cr
87.87
Mar2017 ₹11 Cr
1.72
Mar2016 ₹10 Cr -

Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,549.1 Cr 4.4% -1.1% 23.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.4%

-1.1%

23.3%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses